The Burman family is making waves in the financial sector by increasing their stake in Religare Enterprises to roughly 30%. This strategic ...

The Delhi High Court has allowed the Burman family's open offer for acquiring a stake in Religare Enterprises Ltd to proceed, despite appea...

Burman family's open offer to acquire 26% additional stake in Religare Enterprises Ltd begins on January 27. The offer targets 9 crore shar...

The Enforcement Directorate (ED) has summoned Dabur India chairman Mohit Burman and three independent directors from Care Health Insurance ...

Sebi directs Religare Enterprises to obtain approvals from all regulators by July 12 for Burman family's open offer to buy more shares. The...

"The merits of the offer are not very good. They want to replace the board and the management," said Ahmed, also the chief executive office...

Once the open offer is concluded, the Burman family-owned entities - currently the largest shareholding bloc at Religare - will nominate th...

MB Finmart, Puran Associates, VIC Enterprises and Milky Investment & Trading Company are the entities that will participate in the open off...

The Burman Group, through its entities Puran Associates, VIC Enterprises, MB Finmart, Gyan Enterprises and Chowdry Associates had increased...

The resignations of Aditya Khaitan and Amritanshu Khaitan come two days after the Burmans of Dabur group made an open offer for the Kolkata...

The mandatory open offer under the takeover regulations of SEBI was made as the Burmans acquired an additional 5.26 per cent stake of Evere...

Making its first ever overseas acquisition, FMCG player Dabur today said it has acquired Turkish personal care firm Hobi Kozmetik Group for...

Dabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.

Dabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...

Fresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...

Days after acquiring 73.3 per cent control of Dabur Pharma, European health care firm Fresenius Kabi on Monday said it would launch a publi...

European health care firm Fresenius Kabi, which acquired 73.3 per cent control of Dabur Pharma last week, today announced a public offer to...